" In calendar 2H21 and 1H22, we look forward to Phase 1 results for PD1-Vaxx (determination of optimal
biological dose as monotherapy and combination therapy, respectively). In calendar 1H22 and 1H23, we look
forward to Phase 2 data for HER-Vaxx (PFS and OS, respectively). Initial Phase 1 results for CHECKvacc and
VAXinia are expected in calendar 2H22, all of which should serve as meaningful investment catalysts."
" In calendar 2H21 and 1H22, we look forward to Phase 1 results...
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.004(6.67%) |
Mkt cap ! $440.9M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.5¢ | $708.1K | 12.36M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 522746 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 801925 | 11 |
View Market Depth
| Last trade - 10.35am 24/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |